Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 6/20 | 0.58 |
| ▸ | KISS1R | Q969F8 | 9/20 | 0.55 |
| ▸ | CTSL | P07711 | 3/20 | 0.55 |
| ▸ | CTSS | P25774 | 3/20 | 0.55 |
| ▸ | CTSK | P43235 | 3/20 | 0.55 |
| ▸ | CTSH | P09668 | 1/20 | 0.55 |
| ▸ | CCKBR | P32239 | 1/20 | 0.52 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12094797 | 1.00 | MC4R (0.58) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL12094764 | 1.00 | MC4R (0.58) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL30418415 | 1.00 | MC4R (0.58) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL12094801 | 1.00 | MC4R (0.58) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL12094755 | 1.00 | MC4R (0.58) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL12094776 | 0.96 | MC4R (0.54) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL16677035 | 0.96 | MC4R (0.59) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL18891547 | 0.96 | MC4R (0.59) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL18556707 | 0.96 | MC4R (0.59) | MC4RKISS1RCTSLCTSSCTSK | |
| SCHEMBL18891478 | 0.96 | MC4R (0.59) | MC4RKISS1RCTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES INC (US) | 2017-05-25 | — | — | US | disclosed |
| US-9580466-B2 | Melanocortin-1 receptor-specific linear peptides | PALATIN TECHNOLOGIES, INC. (US) | 2017-02-28 | — | — | US | disclosed |
| US-20150119341-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES INC (US) | 2015-04-30 | — | — | US | disclosed |
| US-8933194-B2 | Melanocortin-1 receptor-specific linear peptides | PALATIN TECHNOLOGIES, INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-20120225831-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES, INC. (US) | 2012-09-06 | — | — | US | disclosed |
| WO-2011063367-A1 | MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDES | PALATIN TECHNOLOGIES, INC. (US) | 2011-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC5R, MC3R | MC4R 4/4885KISS1R 188/4885CTSL 3250/4885 |
| US-20150119341-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC3R, MC5R | MC4R 4/4885KISS1R 93/4885CTSL 2983/4885 |
| US-20120225831-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC3R, MC5R | MC4R 4/4885KISS1R 93/4885CTSL 2983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.